Exact Sciences Appoints New CFO, Boyer
Ticker: EXAS · Form: 8-K · Filed: 2024-06-03T00:00:00.000Z
Sentiment: neutral
Topics: executive-appointment, cfo, compensation
TL;DR
Exact Sciences just hired a new CFO, Dr. Jeffrey S. Boyer, starting June 3rd. He's getting $500k base + stock.
AI Summary
Exact Sciences Corp. announced on May 30, 2024, the appointment of Dr. Jeffrey S. Boyer as Chief Financial Officer, effective June 3, 2024. Dr. Boyer previously served as CFO of Cerner Corporation and will receive an annual base salary of $500,000, along with other compensation and equity awards.
Why It Matters
The appointment of a new CFO is a significant leadership change that can impact investor confidence and the company's financial strategy.
Risk Assessment
Risk Level: medium — Changes in key executive positions like CFO can introduce uncertainty regarding future financial strategies and performance.
Key Numbers
- $500,000 — CFO Base Salary (Annual compensation for Dr. Boyer)
Key Players & Entities
- Exact Sciences Corp. (company) — Registrant
- Dr. Jeffrey S. Boyer (person) — Newly appointed Chief Financial Officer
- $500,000 (dollar_amount) — Annual base salary for new CFO
- June 3, 2024 (date) — Effective date of CFO appointment
- Cerner Corporation (company) — Previous employer of new CFO
FAQ
Who is the new Chief Financial Officer of Exact Sciences Corp.?
Dr. Jeffrey S. Boyer has been appointed as the new Chief Financial Officer of Exact Sciences Corp.
When does Dr. Jeffrey S. Boyer's appointment become effective?
Dr. Boyer's appointment is effective as of June 3, 2024.
What is the annual base salary for the new CFO?
The annual base salary for Dr. Jeffrey S. Boyer is $500,000.
Where did Dr. Boyer previously work?
Dr. Boyer previously served as the Chief Financial Officer of Cerner Corporation.
What other compensation will Dr. Boyer receive?
In addition to his base salary, Dr. Boyer will be eligible to receive other compensation and equity awards as determined by the Compensation Committee.
From the Filing
0001124140-24-000051.txt : 20240603 0001124140-24-000051.hdr.sgml : 20240603 20240603070105 ACCESSION NUMBER: 0001124140-24-000051 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240530 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP CENTRAL INDEX KEY: 0001124140 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 204782291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35092 FILM NUMBER: 241011963 BUSINESS ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 BUSINESS PHONE: 608-284-5700 MAIL ADDRESS: STREET 1: 5505 ENDEAVOR LANE CITY: MADISON STATE: WI ZIP: 53719 FORMER COMPANY: FORMER CONFORMED NAME: EXACT CORP DATE OF NAME CHANGE: 20000919 8-K 1 exas-20240530.htm 8-K exas-20240530 0001124140 false 0001124140 2024-05-30 2024-05-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported):  May 30, 2024   EXACT SCIENCES CORPORATION (Exact Name of Registrant as Specified in Charter)   Delaware   001-35092   02-0478229 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   5505 Endeavor Lane Madison , WI   53719 (Address of Principal Executive Offices)(Zip Code)   Registrant’s telephone number, including area code:   ( 608 ) 284-5700   Not Applicable (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐              Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share EXAS The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02.                      Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory